Back

Cardiotoxicity patterns and outcomes in cardio-oncology: differences between hematologic and solid malignancies

10 May 2026 (14:55 - 16:12)
Organised by: Logo
Congress Presentation Part of: ePosters in cardiovascular disease in special populations (1) Cardio-Oncology HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Isabel Nobrega Fernandes

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

6 More presentations in this session

Presentation thumbnail
Early diastolic dysfunction in sarcoidosis without overt cardiac involvement
Miss J. Conde Goncalves (Porto, PT)
Abstract Slides
Presentation thumbnail
Cardiorespiratory fitness-based markers of vulnerability to chemotherapy-induced cardiac dysfunction in non-Hodgkin lymphoma
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Reversibility of subclinical left ventricular dysfunction detected by global longitudinal strain during cancer therapy.
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides
Presentation thumbnail
Changes in ventricular function and myocardial deformation in patients treated with trastuzumab.
Doctor M. Costales Pavon (Seville, ES)
Abstract Slides
Presentation thumbnail
Incidence and characterization of myocarditis among a retrospective cohort of patients receiving immune checkpoint inhibitors
Doctor K. Paik (Winston Salem, US)
Abstract Slides

Access the full session

Session thumbnail
ePosters in cardiovascular disease in special populations (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 14:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources